PHILADELPHIA--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, was named Life Sciences and Healthcare Company by PACT, the Philadelphia Alliance for Capital and Technologies, at the 2023 PACT Enterprise Awards. The Enterprise Awards ranks as the most prestigious business honors for technology and life sciences companies, leaders and entrepreneurs in the Philadelphia region.
“Every year, the list of finalists and winners continues to impress and inspire all of us at PACT,” said Dianne Strunk, Vice President, PACT. “The Enterprise Awards celebrates Philadelphia’s technology and life sciences ecosystem, bringing together a diverse group of individuals and organizations solving some of the world’s most complex challenges. On behalf of my PACT colleagues, I offer sincere congratulations to AscellaHealth for being recognized as the Life Sciences and Healthcare Company at the 2023 PACT Enterprise Awards.”
AscellaHealth is a global healthcare and specialty pharmacy services organization, providing cutting-edge, tech-enabled solutions for specialty and rare disease patients, life sciences manufacturers, payers and providers, to improve medication access and clinical outcomes. End-to-end, customized support for life sciences manufacturers and payer clients includes:
- Pre-Commercialization & Market Access
- International Specialty Pharmacy Fulfillment
- Exclusive Distribution Partnerships
- Wholesaler and 3PL
- Financial & Copay Assistance Programs
- Patient Support & HUB Services
- Rx Data & Analytics
- Specialty Medical & Pharmacy Benefit Management
“We are delighted to be recognized by PACT as this year’s leading Life Sciences and Healthcare Company,” says Dea Belazi, president and CEO, AscellaHealth. “This honor is a testament to AscellaHealth’s tremendous growth and points to the achievements of our team of experienced professionals and deep rare and specialty disease expertise. Our passion for patient-centric care, supported by unique, innovative and tech-enabled solutions, position AscellaHealth as the leading strategic, single-source partner to industry stakeholders. Manufacturers worldwide now turn to AscellaHealth for a customized approach that provides solutions throughout the product lifecycle and beyond, addressing unmet needs and market challenges. We value this award which is a further salute to our approach: enhancing access to lifesaving medications and improving health outcomes and quality of life for patients with complex, chronic conditions or rare diseases.”
About Philadelphia Alliance for Capital and Technologies (PACT)
PACT’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching, and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region. www.philadelphiapact.com.
About AscellaHealth LLC
AscellaHealth, a global Healthcare & Specialty Pharmacy solutions organization, serving patients, life sciences manufacturers, payers and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. A recipient of numerous industry awards for innovation, and a NASP Strategic Channel Partner of the Year award winner, AscellaHealth’s best-in-class, patient-centric approach is built upon proprietary technology processes for novel programs and services to support the launch of specialty medications and proactively address multiple challenges, optimize clinical health outcomes, and improve quality of life for this patient population. AscellaHealth brings a rare and special perspective to all stakeholders. Visit www.AscellaHealth.com.
